Despite "serious objections" from the Royal Dutch Medical Association (KNMG), Menzis, one of the Netherlands largest health insurers, has won a court battle to pay bonuses to doctors who meet targets for prescribing generic drugs.
The main concern for medical professionals was that such a development would signal the end of doctors' independence when prescribing drugs. However, the ruling states that "there is nothing to show that doctors would deviate from these simply because of the bonus."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze